Bristol-Myers Squibb Company Common Stock (BMY)

About BMY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Its products include Opdivo for anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumors; Orencia for active rheumatoid arthritis and…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

32,500

Website

www.bms.com

Fundamentals

1-day range

$66.21$67.47

Market cap

$133.74B

P/E (trailing)

14.21

P/E (forward)

10.21

EPS (trailing)

$4.54

Dividend yield

4.58%

Beta

0.18

Avg. volume

12.21M

Ex-dividend date

July 2, 2026

Dividend pay date

August 3, 2026

Forecasts

24 analyst ratings

Bristol-Myers Squibb Company Common Stock Competitors

Chosen by industry and closest market cap.

• BMY

  Bristol-Myers Squibb Company Common Stock

  $66.58

  ▼ 0.55%
  Market cap $133.74BP/E 14.21
  $42.52$68.64
• PFE

  Pfizer Inc. Common Stock

  $27.95

  ▼ 0.25%
  Market cap $142.66BP/E 35.19
  $23.58$28.75
• VRTX

  Vertex Pharmaceuticals Incorporated Common Stock

  $541.72

  ▼ 1.06%
  Market cap $119.47BP/E 30.70
  $374.17$555.69
• SNY

  Sanofi ADS

  $44.82

  ▼ 0.04%
  Market cap $104.75BP/E 16.24
  $71.25$91.15
• GSK

  GSK plc American Depositary Shares (Each representing two Ordinary Shares)

  $50.82

  ▲ 1.09%
  Market cap $104.31BP/E 15.53
  $1,441$2,282
• ABT

  Abbott Laboratories Common Stock

  $112.42

  ▲ 0.74%
  Market cap $185.36BP/E 35.52
  $81.97$137.49
• NVO

  Novo Nordisk A/S Common Stock

  $45.6

  ▼ 1.43%
  Market cap $208.51BP/E 11.40
  $224.25$409.95

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Buy 4 Barron's Better Bets (Than T-Bills) Out Of 11 'Safer' August DiviDogs
  SeekingAlpha · 8/22/2026
• Bristol-Myers Squibb (BMY) Bets $2.3 Billion on Texas While Eli Lilly (LLY) Wins in the UK
  Yahoo · 8/21/2026
• Most Of What Moves AbbVie Stock Has Nothing To Do With The Market
  Yahoo · 8/21/2026
• Can Eliquis Cushion Bristol Myers' Legacy Portfolio Erosion?
  Yahoo · 8/21/2026
• JANX Shares Gain 19.1% in 3 Months: Here's What You Need to Know
  Yahoo · 8/21/2026
• Shareholder pressures Capricor; Lilly dives deeper into vaccines
  Yahoo · 8/21/2026
• What Could Bristol Myers Squibb (BMY) AI Antibody Deal Mean For Drug Discovery?
  Yahoo · 8/21/2026
• Merck Stock Ran On A Checklist Published In Advance
  Yahoo · 8/20/2026

• Cristian Massacesi · August 1, 2026 · Option Exercise

  51.2K
• Cristian Massacesi · August 1, 2026 · Tax Withholding

  26.2K @ $65.31
• Cari Gallman · August 1, 2026 · Option Exercise

  1.1K
• Cari Gallman · August 1, 2026 · Tax Withholding

  543 @ $65.31
• Theodore R. Samuels II · June 30, 2026 · Grant

  889 @ $57.62
• McMullen Michael R. · June 30, 2026 · Grant

  607 @ $57.62
• Derica W. Rice · June 30, 2026 · Grant

  673 @ $57.62
• Peter J. Arduini · June 30, 2026 · Grant

  607 @ $57.62
• Phyllis R. Yale · June 30, 2026 · Grant

  607 @ $57.62
• Julia A. Haller · June 15, 2026 · Option Exercise

  20.5K @ $53.76
• Bartie Wendy Short · June 3, 2026 · Option Exercise

  8.0K
• Bartie Wendy Short · June 3, 2026 · Tax Withholding

  3.9K @ $54.72
• Adam Lenkowsky · May 1, 2026 · Option Exercise

  1.4K
• Adam Lenkowsky · May 1, 2026 · Tax Withholding

  599 @ $58.22
• Adam Lenkowsky · May 1, 2026 · J

  203

Institutional Ownership

March 31, 2026

Total shares held

1.49B

Total value held

$85.53B

Institutional holders

2506